BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22570941)

  • 1. Influence of lipid imbalance on butyrylcholinesterase activity and biotransformation efficiency.
    Sisková K; Bilka F; Adameová A; Balazová A; Mydla M; Pauliková I
    Pharmazie; 2012 Apr; 67(4):345-50. PubMed ID: 22570941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymes cooperating in the hydrolyzing process of benzoylcholines: subcellular and inter-tissue comparison.
    Pauliková I; Sisková K
    Pharmazie; 2009 Jun; 64(6):398-402. PubMed ID: 19618678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of deltamethrin metabolism by rat plasma and liver microsomes.
    Anand SS; Bruckner JV; Haines WT; Muralidhara S; Fisher JW; Padilla S
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):156-66. PubMed ID: 16169030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of simvastatin and fenofibrate on butyrylcholinesterase activity in the brain, plasma, and liver of normolipidemic and hyperlipidemic rats.
    Vukšić A; Lovrić J; Konjevoda P; Blažević N; Bilušić M; Bradamante V
    Arh Hig Rada Toksikol; 2019 Mar; 70(1):30-35. PubMed ID: 30956215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum butyrylcholinesterase activity in dogs with diabetes mellitus.
    Tvarijonaviciute A; Ceron JJ; Caldin M
    Vet J; 2012 Jun; 192(3):494-7. PubMed ID: 21820337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.
    Duysen EG; Lockridge O
    Chem Biol Interact; 2008 Sep; 175(1-3):119-24. PubMed ID: 18486120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics.
    Masson P; Schopfer LM; Froment MT; Debouzy JC; Nachon F; Gillon E; Lockridge O; Hrabovska A; Goldstein BN
    Chem Biol Interact; 2005 Dec; 157-158():143-52. PubMed ID: 16256969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine detoxification by human plasma butyrylcholinesterase.
    Lynch TJ; Mattes CE; Singh A; Bradley RM; Brady RO; Dretchen KL
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):363-71. PubMed ID: 9266810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase activity and plasma lipids in dexamethasone treated rats.
    Lucić Vrdoljak A; Bradamante V; Radić B; Peraica M; Fuchs R; Reiner Z
    Acta Pharm; 2005 Jun; 55(2):177-85. PubMed ID: 16179131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
    Duysen EG; Lockridge O
    Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of butyrylcholinesterase for cocaine intoxication.
    Mattes CE; Lynch TJ; Singh A; Bradley RM; Kellaris PA; Brady RO; Dretchen KL
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):372-80. PubMed ID: 9266811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fenofibrate on lipid metabolism in adipose tissue of rats.
    Ferreira AV; Parreira GG; Green A; Botion LM
    Metabolism; 2006 Jun; 55(6):731-5. PubMed ID: 16713430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in butyrylcholinesterase activity and serum lipids after oxprenolol and glibenclamide treatments in non-diabetic rats.
    Bradamante V; Krnić Z; Zrinski R; Konjevoda P; Reiner Z
    Arzneimittelforschung; 2006; 56(2):64-9. PubMed ID: 16572919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity.
    Boopathy R; Rajesh RV; Darvesh S; Layer PG
    Clin Chim Acta; 2007 May; 380(1-2):151-6. PubMed ID: 17379201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
    Chilukuri N; Duysen EG; Parikh K; diTargiani R; Doctor BP; Lockridge O; Saxena A
    Mol Pharmacol; 2009 Sep; 76(3):612-7. PubMed ID: 19542320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase and butyrylcholinesterase activity in the human term placenta: implications for fetal cocaine exposure.
    Simone C; Derewlany LO; Oskamp M; Johnson D; Knie B; Koren G
    J Lab Clin Med; 1994 Mar; 123(3):400-6. PubMed ID: 8133152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress.
    Rahimi Z; Ahmadi R; Vaisi-Raygani A; Rahimi Z; Bahrehmand F; Parsian A
    J Matern Fetal Neonatal Med; 2013 Nov; 26(16):1590-4. PubMed ID: 23650977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
    Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.